Dear Dr. Tengku Din,Good day.I'm Ensley, an assistant editor of Exploration of Targeted Anti-tumor Therapy. Glad to contact you.In light of your expertise, I'm writing to sincerely invite you to review a manuscript ETAT-D-24-00025 entitled “Evaluation of HER2 Immunohistochemistry Expression in Non-Standard Solid Tumors from a Single-Institution Prospective Cohort”for our journal.The default review time is 14 days and the manuscript information is below the email for your reference.Could you please let me know whether you would accept the invitation to review this manuscript at your earliest convenience? If you accept the invitation, please reply to me and I will send you the full-text review link so that you could process the review. If you are unavailable this time, we would appreciate you recommending another expert.Thank you for your consideration.

Hello Tengku Ahmad Damitri Al-AstaniWe haven't heard from you in a while, so please get in touch to know your interest in the 3rd International Conference on Cancer Science and Therapy set to occur in Bangkok, Thailand from May 06-07, 2024.We are happy to welcome you and your student to join our conference as Speakers.Also, as per your request, we are glad to extend the scholarship benefits to your student to join our event.To proceed further, kindly submit your abstract of presentation at https://www.cancer.scientexconference.com/submitabstract Once your abstract gets screened through the review process successfully, you will be prompted towards the registration process to confirm your participation slot in the conference.Once you both confirm your participation, you will be provided with the official letter of invitation.We appreciate your soonest response.

Tue 5/28/2024 7:59 PMMy name is Saeeda Akbar, and I am keen on participating in research within Breast Cancer.I am currently enrolled  at the University of Lincoln .I have published three articles in HEC recognized journal.Having reviewed your faculty profile and ad about breast cancer. I am eager to contribute to breast cancer area of study as it aligns with my long-term goals.Could we schedule a meeting to discuss and my potential involvement in your research? I am available on 2nd June . I appreciate your consideration and look forward to hearing from you.Respectfully,

Dear Dr. Din, Thank you for reaching out. To participate we ask you to write either an original research paper or a review paper based on your latest research. Your paper would be published as an Open Access chapter in this book. Your submission can be a theoretical or an applied scientific paper or a review paper. Some potential research subjects and keywords are: Metastasis, Recurrence, Immune Evasion, Heterogeneity, Chemotherapy. Please note that the keywords are here to guide you, but you don't have to strictly adhere to them, you are welcome to write about any topic as long as it falls under the scope of the book. For the participation process, your first step should be to complete your registration and accept the Terms and Conditions, including the Chapter Processing Charge*. You will then be asked to submit a chapter proposal, which should consist of a title, 5-6 keywords, and a short summary (100-150 words) of your future full chapter. Feel free to write about any topic that interests you, as long as it fits the scope of the book. Only after the editor's approval of your proposal will you proceed to write a full chapter that should be 10-20 pages long. Upon registration, you will gain access to your Author Panel, where you can find all the important guidelines, documents, and more detailed instructions regarding the publishing process steps. As an author, you have two deadlines to follow. The first one is the chapter proposal deadline, due on April 17, 2024, and the second is the deadline for the full chapter, which is due on June 14, 2024.

Tumor microenvironment (TME)

The author discusses breast cancer in order to __________.give an example of the medicines involved in the reported issuesshow how Roche is renowned for medicines for breast canceremphasize the possible side effects of breast cancerdemonstrate that breast cancer is one of the most common cancersI don't know